Evidence map›Paper›PMID 42000960›Full record

ArticleApplied microbiology and biotechnology2026

The p40 fusion domain as a scaffold for producing functional inclusion bodies.

Santhosh Vijayakumar, Riya Khetan, Anwar Sunna

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Santhosh Vijayakumar *School of Natural Sciences, Macquarie University, North Ryde, Sydney, NSW, 2109, Australia.ORCID http://orcid.org/0009-0003-2964-9559
Riya Khetan *School of Natural Sciences, Macquarie University, North Ryde, Sydney, NSW, 2109, Australia.ORCID http://orcid.org/0000-0001-5166-8930
Anwar SunnaSchool of Natural Sciences, Macquarie University, North Ryde, Sydney, NSW, 2109, Australia. anwar.sunna@mq.edu.au.ORCID http://orcid.org/0000-0002-1467-9937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inclusion bodies (IBs) in Escherichia coli were once regarded as undesirable aggregates of misfolded proteins, but are now increasingly recognised as functional biomaterials. Here, we show that the N-terminal p40 domain of a lytic polysaccharide monooxygenase from Caldibacillus cellulovorans acts as a scaffold for producing functional inclusion bodies. This property was demonstrated across diverse proteins, including the fluorescent protein mCherry, three industrially relevant enzymes, and the antimicrobial peptide ZXR-2. The p40 domain consistently promoted IB formation under a wide range of induction conditions, and the resulting protein nanoparticles retained enzymatic activity, could be reused over multiple reaction cycles, and, when fused to ZXR-2, exhibited both antimicrobial and cytotoxic activities. Biophysical analyses revealed that IB size and morphology were influenced by cultivation parameters, highlighting the tunability of p40-mediated assemblies. Comparative analyses underscored the structural robustness of p40-driven IBs and their ability to support diverse protein contexts. While not intended for direct therapeutic use, these results emphasise the potential of p40 IBs as a platform technology for in vitro studies, biocatalysis, and other biotechnological applications. These findings establish the p40 fusion domain as a reliable scaffold for functional inclusion body production in E. coli, providing a foundation for future applications of IBs as versatile biotechnological tools. KEY POINTS: • p40 serves as a versatile scaffold for active protein aggregates in E. coli. • Cultivation parameters modulate aggregates accumulation and physical properties. • p40 fusions form recyclable nanobiocatalysts and stabilise antimicrobial peptides.

Indexed as

Escherichia coliInclusion BodiesMixed Function OxygenasesRecombinant Fusion ProteinsAntimicrobial PeptidesProtein DomainsAntimicrobial PeptidesMixed Function OxygenasesRecombinant Fusion ProteinsAntimicrobial peptideBiocatalysisEnzyme immobilisationFusion tagsProtein aggregationRecyclable biocatalysts

Identifiers

PMID42000960
PMCPMC13219152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.